Trials / Completed
CompletedNCT05873660
A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
Multi-centre Cross-sectional Observational Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,360 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given |
Timeline
- Start date
- 2023-06-12
- Primary completion
- 2024-06-24
- Completion
- 2024-06-24
- First posted
- 2023-05-24
- Last updated
- 2024-07-11
Locations
5 sites across 5 countries: United States, Brazil, Canada, Saudi Arabia, Spain
Source: ClinicalTrials.gov record NCT05873660. Inclusion in this directory is not an endorsement.